In the ARISTOTLE trial, for apixaban, the exclusion criteria conditions were AST or ALT 2x ULN or total bilirubin > 1.5x ULN, hemoglobin < 9 g/dL, or thrombocytopenia < 100.000/mm3 [25]. Here, GPT is linked to Thrombocytopenia.